Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T cells Therapy in ALL patients
TCTR20220624004Phase 2Unknown
- Sponsor
- Genepeutic Bio
- Start
- Jul 2023
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of LV20.19 CAR-T in acute lymphoblastic leukemia (ALL), sponsored by Genepeutic Bio. Status: unknown.
02
Drugs
LV20.19 CAR-T
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on TCTR20220624004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220624004.